Alter Pharma Group News Today

/PRNewswire/ -- According to Prophecy Market Insights "Generic Sterile Injectables Market accounted for US$ 68.7 billion in 2019 and is estimated to be US$ 196....

COVINA, Calif., May 9, 2023 /PRNewswire/ -- According to Prophecy Market Insights "Generic Sterile Injectables Market accounted for US$ 68.7 billion in 2019 and is estimated to be US$ 196.2

01.09.2022 - - On track to broaden product pipeline to meet a target portfolio of 30 programs by 2024- Continued commercial rollout of Sotalol IV in US and Maxigesic IV - Focused entry into US market with Maxigesic IV for non-opioid pain treatment; continuing ...

Alter Pharma, a Belgian pharmaceutical group focused on the distribution of medicines and the development and manufacturing of generic drugs commercialized in Europe, the US (through its wholly owned

Alter Pharma, a Belgian pharmaceutical group focused on the distribution of medicines and the development and manufacturing of generic drugs commercialized in Europe, the US (through its wholly owned

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Added 4 additional innovative product candidates Strong growth in H2 leading to total revenues of €3.1 million (€0.2 million in 2020) Significant expansion of commercial footprint of Maxigesic

Added 4 additional innovative product candidates Strong growth in H2 leading to total revenues of €3.1 million Significant expansion of commercial footprint of Maxigesic® IV ... | March 16, 2022

Investegate announcements from Hyloris Pharmaceuticals SA, Hyloris reports results for the full year 2021

Hyloris reports results for the full year 2021 - read this article along with other careers information, tips and advice on BioSpace